{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:10:09Z","timestamp":1759342209091},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.actatropica.2008.08.005","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T13:17:22Z","timestamp":1220793442000},"page":"20-25","source":"Crossref","is-referenced-by-count":11,"title":["In vivo activity of perifosine against Leishmania amazonensis"],"prefix":"10.1016","volume":"108","author":[{"given":"M. Gabriela","family":"Cabrera-Serra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basilio","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose E.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2008.08.005_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1742-7843.2005.pto960109.x","article-title":"Leishmanicidal activity of edelfosine, miltefosine and ilmofosine","volume":"96","author":"Azzouz","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.actatropica.2008.08.005_bib2","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.trstmh.2006.02.009","article-title":"Miltefosine: issues to be addressed in the future","volume":"100","author":"Berman","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2008.08.005_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2008.08.005_bib4","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration\u2014a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.08.005_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00436-006-0408-4","article-title":"In vitro activity of perifosine: a novel alkylphospholipid against the promastigote stage of Leishmania species","volume":"100","author":"Cabrera-Serra","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2008.08.005_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2008.08.005_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actatropica.2008.08.005_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.08.005_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0074-02762000000400006","article-title":"Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania amazonensis","volume":"95","author":"De S\u00e1 Oliveira","year":"2000","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2008.08.005_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2008.08.005_bib11","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","article-title":"Activities of hexadecylphosphocholine (miltefosine), ambisome, and sodium stibogluconate (pentostam) against Leishmania donovani in immunodeficient scid mice","volume":"45","author":"Escobar","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.08.005_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10637-006-6406-7","article-title":"Phase II study of Perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: a National Cancer Institute of Canada clinical trials group trial","volume":"24","author":"Knowling","year":"2006","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.actatropica.2008.08.005_bib13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocholine\u2014oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.08.005_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-4758(96)40010-2","article-title":"A simple method for quantifying Leishmania in tissues of infected animals","volume":"13","author":"Lima","year":"1997","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.actatropica.2008.08.005_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","article-title":"A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue","volume":"48","author":"Mikus","year":"2000","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2008.08.005_bib16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2008.08.005_bib17","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/AAC.49.12.4950-4956.2005","article-title":"Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases","volume":"49","author":"Nakayama","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.08.005_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis\u2014a systematic review of clinical studies done in India 1980\u20132004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.08.005_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis\u2014drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.actatropica.2008.08.005_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2008.08.005_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-065X.2006.00432.x","article-title":"Immune privilege in sites of chronic infection\u2014Leishmania and regulatory T cells","volume":"213","author":"Peters","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actatropica.2008.08.005_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.actatropica.2006.02.001","article-title":"New administration model of trans-chalcone biodegradable polymers for the treatment of experimental leishmaniasis","volume":"98","author":"Pi\u00f1ero","year":"2006","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2008.08.005_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/13543776.14.8.1113","article-title":"Advances in leishmaniasis chemotherapy and new relevant patents","volume":"14","author":"Pi\u00f1ero","year":"2004","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.actatropica.2008.08.005_bib24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/cbt.4.10.2064","article-title":"A phase II study of perifosine in androgen independent prostate cancer","volume":"4","author":"Posadas","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.actatropica.2008.08.005_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jac\/dkh380","article-title":"Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis","volume":"54","author":"Santa-Rita","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2008.08.005_bib26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.08.005_bib27","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.trstmh.2006.02.022","article-title":"Treatment of new world cutaneous leishmaniasis with miltefosine","volume":"100","author":"Soto","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2008.08.005_bib28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00436-002-0695-3","article-title":"A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species","volume":"88","author":"Teixeira","year":"2002","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2008.08.005_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X08002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X08002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T16:59:25Z","timestamp":1557766765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X08002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0001706X08002222"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2008.08.005","relation":{},"ISSN":["0001-706X"],"issn-type":[{"type":"print","value":"0001-706X"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}